Szczegóły publikacji
Opis bibliograficzny
Physicochemical and biological characterisation of diclofenac oligomeric poly(3-hydroxyoctanoate) hybrids as $\beta-TCP$ ceramics modifiers for bone tissue regeneration / Katarzyna Haraźna, Ewelina CICHOŃ, Szymon SKIBIŃSKI, Tomasz Witko, Daria Solarz, Iwona Kwiecień, Elena Marcello, Małgorzata Zimowska, Robert Socha, Ewa Szefer, Aneta ZIMA, Ipsita Roy, Konstantinos N. Raftopoulos, Krzysztof Pielichowski, Małgorzata Witko, Maciej Guzik // International Journal of Molecular Sciences [Dokument elektroniczny]. — Czasopismo elektroniczne ; ISSN 1422-0067 . — 2020 — vol. 21 iss. 24 art. no. 9452, s. 1–23. — Wymagania systemowe: Adobe Reader. — Bibliogr. s. 19–22, Abstr. — Publikacja dostępna online od: 2020-12-11
Autorzy (16)
- Haraźna Katarzyna
- AGHCichoń Ewelina
- AGHSkibiński Szymon
- Witko Tomasz
- Solarz Daria
- Kwiecień Iwona
- Marcello Elena
- Zimowska Małgorzata
- Socha Robert P.
- Szefer Ewa
- AGHZima Aneta
- Roy Ipsita
- Raftopoulos Konstantinos N.
- Pielichowski Krzysztof
- Witko Małgorzata
- Guzik Maciej
Słowa kluczowe
Dane bibliometryczne
| ID BaDAP | 131537 |
|---|---|
| Data dodania do BaDAP | 2020-12-12 |
| Tekst źródłowy | URL |
| DOI | 10.3390/ijms21249452 |
| Rok publikacji | 2020 |
| Typ publikacji | artykuł w czasopiśmie |
| Otwarty dostęp |  |
| Creative Commons | |
| Czasopismo/seria | International Journal of Molecular Sciences |
Abstract
Nowadays, regenerative medicine faces a major challenge in providing new, functional materials that will meet the characteristics desired to replenish and grow new tissue. Therefore, this study presents new ceramic-polymer composites in which the matrix consists of tricalcium phosphates covered with blends containing a chemically bounded diclofenac with the biocompatible polymer—poly(3-hydroxyoctanoate), P(3HO). Modification of P(3HO) oligomers was confirmed by NMR, IR and XPS. Moreover, obtained oligomers and their blends were subjected to an in-depth characterisation using GPC, TGA, DSC and AFM. Furthermore, we demonstrate that the hydrophobicity and surface free energy values of blends decreased with the amount of diclofenac modified oligomers. Subsequently, the designed composites were used as a substrate for growth of the pre-osteoblast cell line (MC3T3-E1). An in vitro biocompatibility study showed that the composite with the lowest concentration of the proposed drug is within the range assumed to be non-toxic (viability above 70%). Cell proliferation was visualised using the SEM method, whereas the observation of cell penetration into the scaffold was carried out by confocal microscopy. Thus, it can be an ideal new functional bone tissue substitute, allowing not only the regeneration and restoration of the defect but also inhibiting the development of chronic inflammation. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
